# Fate Therapeutics Inc: Form SCHEDULE 13D/A, filed Dec 26, 2024

- Company: [Fate Therapeutics Inc](/companies/fate.md) (CIK 1434316)
- Form: SCHEDULE 13D/A
- Filed: 2024-12-26
- Accepted by EDGAR: Dec 26, 2024, 21:00 ET
- Period: not reported
- Accession: 0001104659-24-131793
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1434316/000110465924131793/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1434316/000110465924131793/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1434316/000110465924131793/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Dec 26, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-131793. Last ingested by Listed: Nov 10, 2026, 05:21 ET. No prices; not investment advice.